AU2015246059A1 - Compositions and methods for quantifying a nucleic acid sequence in a sample - Google Patents

Abstract

The present invention features compositions and methods for quantifying detection of a target oligonucleotide in sample real time. These methods are compatible with target oligonucleotides amplified using a NEAR reaction.

Description

WO 2013/155056 PCT/US2013/035750 COMPOSITIONS AND METHODS FOR QUANTIFYING A NUCLEIC ACID SEQUENCE IN A SAMPLE CROSS-REFERENCE TO RELATED APPLICATIONS 5 This application claims the benefit of U.S. Provisional Application No. 61/621,975, filed April 9, 2012, which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION Nucleic acid amplification technologies have provided a means of understanding 10 complex biological processes, detection, identification, and quantification of pathogenic and non-pathogenic organisms, forensic criminology analysis, disease association studies, and detection of events in genetically modified organisms, etc. The polymerase chain reaction (PCR) is a common thermal cycling dependent nucleic acid amplification technology used to amplify DNA consisting of cycles of repeated heating and cooling of the reaction for DNA 15 melting and enzymatic replication of the DNA using a DNA polymerase. Real-Time quantitative PCR (qPCR) is a technique used to quantify the number of copies of a given nucleic acid sequence in a biological sample. Currently, qPCR utilizes the detection of reaction products in real-time throughout the reaction and compares the amplification profile to the amplification of controls which contain a known quantity of nucleic acids at the 20 beginning of each reaction (or a known relative ratio of nucleic acids to the unknown tested nucleic acid). The results of the controls are used to construct standard curves, typically based on the logarithmic portion of the standard reaction amplification curves. These values are used to interpolate the quantity of the unknowns based on where their amplification curves compared to the standard control quantities. 25 In addition to PCR, non-thermal cycling dependent amplification systems or isothermal nucleic acid amplification technologies exist including, without limitation: Nicking and Extension Amplification Reaction (NEAR), Rolling Circle Amplification (RCA), Helicase-Dependent Amplification (HDA), Loop-Mediated Amplification (LAMP), Strand Displacement Amplification (SDA), Transcription-Mediated Amplification (TMA), 30 Self-Sustained Sequence Replication (3SR), Nucleic Acid Sequence Based Amplification (NASBA), Single Primer Isothermal Amplification (SPIA), Q-0 Replicase System, and Recombinase Polymerase Amplification (RPA). 1 WO 2013/155056 PCT/US2013/035750 NEAR amplification has similarities to PCR thermocycling. Like PCR, NEAR amplification employs oligonucleotide sequences which are complementary to a target sequences referred to as primers in PCR and templates in NEAR. In addition, NEAR amplification of target sequences results in a logarithmic increase in the target sequence, just 5 as it does in standard PCR. Unlike standard PCR, the NEAR reaction progresses isothermally. In standard PCR, the temperature is increased to allow the two strands of DNA to separate. In a NEAR reaction, the target nucleic acid sequence is nicked at specific nicking sites present in a test sample. The polymerase infiltrates the nick site and begins complementary strand synthesis of the nicked target nucleotide sequence (the added 10 exogenous DNA) along with displacement of the existing complimentary DNA strand. The strand displacement replication process obviates the need for increased temperature. At this point, template/primer molecules anneal to the displaced complementary sequence from the added exogenous DNA. The polymerase now extends from the 3' end of the template, creating a complementary strand to the previously displaced strand. The second 15 template/primer oligonucleotide then anneals to the newly synthesized complementary strand and extends making a duplex of DNA which includes the nicking enzyme recognition sequence. This strand is then liable to be nicked with subsequent strand displacement extension by the polymerase, which leads to the production of a duplex of DNA which has nick sites on either side of the original target DNA. Once this is synthesized, the molecule 20 continues to be amplified exponentially through replication of the displaced strands with new template molecules. In addition, amplification also proceeds linearly from each product molecule through the repeated action of the nick translation synthesis at the template introduced nick sites. The result is a very rapid increase in target signal amplification; much more rapid than PCR thermocycling, with amplification results in less than ten minutes. 25 Quantification has been problematic, however. Optimal performance of a real-time NEAR system depends on the generation and amplification of a specific product. NEAR systems are known to generate significant levels of non-specific background products in addition to the specific product by the reaction enzymes. These background products can serve as amplifiable entities and their generation can out-compete the generation of specific 30 product. While it is possible to design detection probes specific to the desired target (and thus the specific product is detectable in a complex background), significant levels of non-specific background products sequester reaction components that may have otherwise been utilized for the amplification of the specific product. Thus, sequestration of reaction components due 2 WO 2013/155056 PCT/US2013/035750 to non-specific background product generation results in a reaction that is suboptimal. This is particularly troublesome when the target nucleic acid is initially in very low abundance and where a highly optimized reaction is required for reliable detection of the target. Also, a suboptimal reaction may not represent true quantification of a target nucleic acid even though 5 it is detectable. It would be advantageous to generate optimized NEAR reactions that eliminate the amplification of non-specific background products. Doing so would provide a reaction that is suitable for quantification either by a standard curve based system or relative quantification. Also, it is common practice to evaluate NEAR reactions using mass spectrometry. 10 High levels of background products can obscure the interpretation of mass spectrometry data. If, for instance, a reaction contains background products, one or more products derived from non-specific amplification (from related yet dissimilar targets), and the specific product, it would be challenging to identify these matrix-derived products from the background products. Elimination of background products leads to a clear determination of the 15 performance/specificity of the particular assay. Additionally, high levels of background products can impede the optimal amplification of intentionally-duplexed or multiplexed reactions. While multiple, differentially labeled detection probes are compatible with real-time detection, there still exists the problem of reactant limitations due to non-specific product formation. This is 20 particularly true for duplex or multiplex reactions in that these reactions contain more than two templates/primers that can potentially form complex populations of background products. A NEAR reaction system that eliminates the amplification of background products also provides conditions for the detection of intentionally duplexed or multiplexed reactions in real time. It would be highly advantageous to provide a means to eliminate amplifiable 25 background products thus maximizing the potential of generating specific products in NEAR reactions. It would be desirable if a quantitative result could be provided by accurately monitoring the progress of the reaction in real-time. SUMMARY OF THE INVENTION 30 As described below, the present invention features compositions and methods for detection of a target oligonucleotide in a sample in real time that reduces or eliminates the generation of background products, allowing for the quantification of the sample target oligonucleotide. These methods are compatible with target oligonucleotides amplified using 3 WO 2013/155056 PCT/US2013/035750 a NEAR reaction. The invention is based, at least in part, on the discovery that specific products in single-plexed NEAR reactions can be generated without the generation of background products. The reaction compositions and methods provide for relative quantification of unknown test samples, duplexed reactions, and multiplexed reactions, and 5 the creation of standard curves for absolute quantification of unknown test samples. In one aspect, the invention provides a method of quantifying a specific product in a nicking and extension amplification reaction, the method involving: contacting a target nucleic acid molecule under substantially isothermal conditions with an exonuclease deficient polymerase, two or more primer/template oligonucleotides, each of which specifically binds 10 to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, where each of the primer/template oligonucleotides has one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule; generating amplicons having at least a portion of said target nucleic acid molecule; and detecting a signal specific for oligonucleotide probe hybridization to the target nucleic 15 acid molecule or amplicon thereof, where the signal indicates the quantity of the target nucleic acid molecule present in the sample or an amplicon thereof. In another aspect, the invention provides a method for detecting a plurality of distinct reaction products produced in the course of a single reaction, the method involving: contacting a target nucleic acid molecule under substantially isothermal conditions with an 20 exonuclease deficient polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, where each of the primer/template oligonucleotides has one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule; generating amplicons having at least a portion of said target 25 nucleic acid molecule; and detecting a signal specific for oligonucleotide probe hybridization to the target nucleic acid molecule or amplicon thereof, where the signal indicates the quantity of the target nucleic acid molecule present in the sample or an amplicon thereof. In a particular aspect, the invention provides a method of quantifying a specific product in a nicking and extension amplification reaction, the method involving: contacting a 30 target nucleic acid molecule under substantially isothermal conditions with an exonuclease deficient polymerase, two primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, where each of the primer/template oligonucleotides has at 4 WO 2013/155056 PCT/US2013/035750 least about 5 contiguous 2'-O-methyl modified nucleotides are positioned at or adjacent to the 3' end of the sequence complementary to the target nucleic acid molecule (e.g., the 3' terminus of the oligonucleotide); generating amplicons having at least a portion of said target nucleic acid molecule; and detecting a signal specific for oligonucleotide probe hybridization 5 to the target nucleic acid molecule or amplicon thereof, where the signal indicates the quantity of the target nucleic acid molecule present in the sample or an amplicon thereof. In one aspect, the invention provides a method for monitoring in real time a nicking and extension amplification reaction, the method involving: contacting a test sample with an exonuclease deficient polymerase, two or more primer/template oligonucleotides, each of 10 which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, where each of the primer/template oligonucleotides has one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule under substantially isothermal conditions; generating amplicons having at least a portion of said target nucleic acid molecule; and detecting a 15 signal in real time, thereby quantitating of the target nucleic acid molecule(s). In another aspect, the invention provides a method for monitoring in real time a target nucleic acid molecule in a NEAR reaction, the method involving: contacting a target nucleic acid molecule under substantially isothermal conditions with an exonuclease deficient polymerase, two or more primer/template oligonucleotides, each of which specifically binds 20 to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, a heteroduplex specific nicking enzyme, and a detectable polynucleotide probe, where each of the primer/template oligonucleotides has one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule; generating amplicons having a target sequence that binds the detectable oligonucleotide probe; and detecting a signal in real time, 25 thereby quantitating the target nucleic acid molecule. In yet another aspect, the invention provides a method for monitoring in real time a target nucleic acid molecule in a test sample, the method involving: contacting a target nucleic acid molecule under substantially isothermal conditions with a polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary 30 sequence on the target nucleic acid molecule, a nicking enzyme, a repair enzyme or proof reading enzyme, and a detectable polynucleotide probe, where each of the primer/template oligonucleotides has one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule; generating amplicons having a target sequence that binds the 5 WO 2013/155056 PCT/US2013/035750 detectable oligonucleotide probe; and detecting a signal in real time, thereby quantitating the target nucleic acid molecule. In still another aspect, the invention provides a kit for detecting a target sequence in a NEAR reaction, the kit containing one or more primer/template oligonucleotides, which 5 specifically binds to a complementary sequence on the target nucleic acid molecule and has one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule, and directions for use of the primer/template oligonucleotide in methods of the invention. In one aspect, the invention provides an isolated oligonucleotide having, from 5' to 3', 10 a first region, and a second region, where the first region has a nicking enzyme recognition sequence; where the second region has at least 9 or more nucleotides (e.g., 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 or more contiguous nucleotides) that specifically bind a complementary sequence on a target nucleic acid molecule; and where the second region has one or more 2' modified nucleotides. In other embodiments, the 15 isolated oligonucleotide is one set forth in Figure 1. In various embodiments of the aspects delineated herein, the oligonucleotide (e.g., primer/template oligonucleotide, isolated oligonucleotide) contains a modified nucleotide, including a 2' modified nucleotide. In various embodiments of any aspect delineated herein, the 2' modification is one or more of a 2'-O-methyl, 2'-methoxyethoxy, 2'-fluoro, 2' 20 hydroxyl, 2'-allyl, 2'-0-[2-(methylamino)-2-oxoethyl], 4'-thio, 4'-CH 2 -0-2'-bridge, 4'-(CH 2 ) 2 0-2-bridge, 2'-LNA, 2'-alkyl, and 2'-O-(N-methylcarbamate) or the modified nucleotide contains a base analog. In various embodiments of any aspect delineated herein, one or more 2' modified nucleotides are positioned at or adjacent to the 3' end of the sequence complementary to the target nucleic acid molecule (e.g., the 3' terminus of the 25 oligonucleotide). In other embodiments of any aspect delineated herein, one or more 2' modified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule. In various embodiments of any aspect delineated herein, one or more 2' modified nucleotides positioned at the 5' end of the sequence complementary to the target nucleic acid molecule are separated from the nick site by 1, 2, 3, 4, 5 or more unmodified 30 nucleotides. In various embodiments of any aspect delineated herein, two or more 2' modified nucleotides are contiguous (2, 3, 4, 5, or more). In other embodiments of any aspect delineated herein, two or more 2' modified nucleotides are alternating with unmodified nucleotides. In various embodiments of any aspect delineated herein, the nicking enzyme 6 WO 2013/155056 PCT/US2013/035750 recognition sequence is 5'-GAGTC-3'. In various embodiments of any aspect delineated herein, 5 contiguous 2'-O-methyl modified nucleotides are positioned at or adjacent to the 3' end of the sequence complementary to the target nucleic acid molecule (e.g., the 3' terminus of the oligonucleotide). In other embodiments of any aspect delineated herein, 5 contiguous 5 2'-O-methyl modified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule. In other embodiments of any aspect delineated herein, 2 or more 2'-0-methyl modified nucleotides alternating with unmodified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule (i.e. target specific region). 10 In various embodiments of any aspect delineated herein, the detecting step does not detect an amplicon of a non-target molecule. In various embodiments of any aspect delineated herein, the method is carried out in real time. In certain embodiments of any aspect delineated herein, the step of generating amplicons is carried out in real time (e.g., to determine the quantity of target present in the reaction). 15 In various embodiments of any aspect delineated herein, the method provides a semi quantitative and/or quantity threshold method of determining the amount of nucleic acid molecule present in a biological sample prior to amplification. In various embodiments of any aspect delineated herein, positioning one or more 2' modified nucleotides nearer the 5' end of the sequence complementary to the target nucleic acid molecule increases the 20 detection time of amplification. In various embodiments of any aspect delineated herein, the method further involves the use of ratios of primer/template oligonucleotides to provide increased resolution of reaction products resulting from differing quantities of starting target material. It has been found that increasing the ratio of primer/template oligo having one or more 2' modified nucleotides at the 3' end of the recognition sequence to primer/template 25 oligo having one or more 2' modified nucleotides at the 5' end of the recognition sequence contracted the signal curve and shifted the slope of the curve. In various embodiments of any aspect delineated herein, the method further involves the use of an amplification rate modifier to provide increased resolution of reaction products resulting from differing quantities of starting target material. In various embodiments of any 30 aspect delineated herein, the target nucleic acid molecule is a DNA or RNA nucleic acid molecule. In various embodiments of any aspect delineated herein, the detectable probe is SYBR green or a Molecular Beacon. In various embodiments of any aspect delineated herein, the detectable probe is a non-amplifiable detectable polynucleotide probe having at 7 WO 2013/155056 PCT/US2013/035750 least about 10 nucleotides that are complementary to a target sequence, a detectable moiety, and a polymerase-arresting molecule, where the polymerase-arresting molecule prevents a polymerase from amplifying the probe under conditions that otherwise support polymerase activity. 5 In various embodiments of any aspect delineated herein, the test sample contains a pathogen. In various embodiments of any aspect delineated herein, the pathogen is a virus, bacteria, yeast or fungus. In various embodiments of any aspect delineated herein, the test sample is a biological sample. In various embodiments of any aspect delineated herein, the biological sample is a cell, tissue sample, or biological fluid (e.g., urine, semen, vaginal 10 secretion, or stool). In various embodiments of any aspect delineated herein, the test sample is an environmental sample. The invention provides compositions and methods for detecting a target nucleic acid molecule amplified using a NEAR reaction. Compositions and articles defined by the invention were isolated or otherwise manufactured in connection with the examples provided 15 below. Other features and advantages of the invention will be apparent from the detailed description, and from the claims. Definitions In this disclosure, "comprises," "comprising," "containing" and "having" and the like 20 can have the meaning ascribed to them in U.S. Patent law and can mean " includes," "including," and the like; "consisting essentially of" or "consists essentially" likewise has the meaning ascribed in U.S. Patent law and the term is open-ended, allowing for the presence of more than that which is recited so long as basic or novel characteristics of that which is recited is not changed by the presence of more than that which is recited, but excludes prior 25 art embodiments. By "polymerase-arresting molecule" is meant a moiety associated with a polynucleotide template/primer that prevents or significantly reduces the progression of a polymerase on the polynucleotide template. Preferably, the moiety is incorporated into the polynucleotide. In one preferred embodiment, the moiety prevents the polymerase from 30 progressing on the template. By "polymerase extension" is meant the forward progression of a polymerase from a accessible 3'-hydroxyl group that incorporates incoming monomers complementary to their opposing nucleotides on a template polynucleotide strand. 8 WO 2013/155056 PCT/US2013/035750 By "exonuclease deficient polymerase" is meant a DNA-dependent DNA polymerase and/or RNA-dependent DNA polymerase that is devoid of a 5'-3' exonuclease activity or that has virtually undetectable levels of such activity. By "nucleotide adduct" is meant a moiety that is bound covalently or otherwise fixed 5 to a standard nucleotide base. As used herein, the term "detectable polynucleotide probe" refers to any, at least partially single stranded, polynucleotide labeled with a detectable moiety with a sequence region complementary to at least one strand of the target sequence, which releases a detectable signal from the detectable moiety upon binding to the target sequence, whereas 10 signal generation by that detectable moiety does depend on cleavage of the detectable polynucleotuide probe by a non-specific 5'-3' exonuclease activity. An example of a "detectable polynucleotide probe" as used herein is, but is not limited to, a fluorescent molecular beacon probe as described in prior art. As used herein, the term "nucleic acid" refers to deoxyribonucleotides, 15 ribonucleotides, or modified nucleotides, and polymers thereof in single- or double-stranded form. The term encompasses nucleic acids containing known nucleotide analogs or modified backbone residues or linkages, which are synthetic, naturally occurring, and non-naturally occurring, which have similar binding properties as the reference nucleic acid, and which are metabolized in a manner similar to the reference nucleotides. Examples of such analogs 20 include, without limitation, 2' modified ribonucleotides (e.g., 2'-O-methyl ribonucleotides, 2'-F nucleotides). As used herein, "modified nucleotide" refers to a nucleotide that has one or more modifications to the nucleoside, the nucleobase, pentose ring, or phosphate group. For example, modified nucleotides exclude ribonucleotides containing adenosine 25 monophosphate, guanosine monophosphate, uridine monophosphate, and cytidine monophosphate and deoxyribonucleotides containing deoxyadenosine monophosphate, deoxyguanosine monophosphate, deoxythymidine monophosphate, and deoxycytidine monophosphate. Modifications include those naturally occuring that result from modification by enzymes that modify nucleotides, such as methyltransferases.. Modified nucleotides also 30 include synthetic or non-naturally occurring nucleotides. Synthetic or non-naturally occurring modifications in nucleotides include those with 2' modifications, e.g., 2'-alkyl, such as 2'-O-methyl and 2'-methoxyethoxy, 2'-fluoro, 2'-hydroxyl (RNA), 2'-allyl, 2'-0-[2 9 WO 2013/155056 PCT/US2013/035750 (methylamino)-2-oxoethyl], 4'-thio, 4'-CH 2 -0-2'-bridge, 4'-(CH 2 ) 2 -0-2'-bridge, 2'-LNA, and 2'-O-(N-methylcarbamate) or those comprising base analogs. By "base substitution" is meant a substituent of a nucleobase polymer that does not cause significant disruption of the hybridization between complementary nucleotide strands. 5 By "specific product" is meant a polynucleotide product resulting from the hybridization of template oligonucleotides to a complementary target sequence and subsequent polymerase mediated extension of the target sequence. By "nicking and extension amplification reaction" is meant alternating cycles of nicking and extension leading to amplification of a polynucleotide of interest. 10 By "substantially isothermal condition" is meant at a single temperature or within a narrow range of temperatures that does not vary significantly. In one embodiment, a reaction carried out under substantially isothermal conditions is carried out at a temperature that varies by only about 1-5' C (e.g., varying by 1, 2, 3, 4, or 5 degrees). In another embodiment, the reaction is carried out at a single temperature within the operating parameters of the 15 instrument utilized. By "nicking enzyme" is meant a polypeptide capable of recognizing and binding to a specific structure in double stranded nucleic acid molecules and breakinga phosphodiester bond between adjoining nucleotides on a single strand upon binding to its recognized specific structure, thereby creating a free 3'-hydroxyl group on the terminal nucleotide upstream of 20 the nick site that can be extended by a exonuclease deficient polymerase. By "nick site" is meant the position of a "broken" phosphodiester bond in one strand of a double stranded nucleic acid molecule hydrolyzed by a nicking enzyme. By "amplicon" is meant a polynucleotide or a multitude of polynucleotides generated during the amplification of a polynucleotide of interest. In one example, an amplicon is 25 generated during a polymerase chain reaction. By "semi-quantitative" is meant providing an estimate of relative quantity based on an internal control. By "quantity threshold method" is meant providing an estimate of quantity based on either exceeding or not exceeding in quantity a comparative standard. 30 By "amplification rate modifiers" is meant an agent capable of affecting either the rate of polymerase extension or the rate of single strand nicking by the nicking enzyme, or both. 10 WO 2013/155056 PCT/US2013/035750 By "monitoring a reaction" is meant detecting the progress of a reaction. In one embodiment, monitoring reaction progression involves detecting polymerase extension and/or detecting a complete NEAR reaction. "Detect" refers to identifying the presence, absence or amount of the analyte to be 5 detected. By "detectable moiety" is meant a composition that when linked to a molecule of interest renders the latter detectable, via spectroscopic, photochemical, biochemical, immunochemical, or chemical means. For example, useful labels include radioactive isotopes, magnetic beads, metallic beads, colloidal particles, fluorescent dyes, electron-dense 10 reagents, enzymes (for example, as commonly used in an ELISA), biotin, digoxigenin, or haptens. By "fragment" is meant a portion of a nucleic acid molecule. This portion contains, preferably, at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, or 90% of the entire length of the reference nucleic acid molecule or polypeptide. A fragment may contain 5, 10, 15, 20, 15 30, 40, 50, 60, 70, 80, 90, or 100 nucleotides. "Hybridization" means hydrogen bonding, which may be Watson-Crick, Hoogsteen or reversed Hoogsteen hydrogen bonding, between complementary nucleobases. For example, adenine and thymine are complementary nucleobases that pair through the formation of hydrogen bonds. 20 By "isolated polynucleotide" is meant a nucleic acid (e.g., a DNA) that is free of the genes which, in the naturally-occurring genome of the organism from which the nucleic acid molecule of the invention is derived, flank the gene. The term therefore includes, for example, a recombinant DNA that is incorporated into a vector; into an autonomously replicating plasmid or virus; or into the genomic DNA of a prokaryote or eukaryote; or that 25 exists as a separate molecule (for example, a cDNA or a genomic or cDNA fragment produced by PCR or restriction endonuclease digestion) independent of other sequences. In addition, the term includes an RNA molecule that is transcribed from a DNA molecule, as well as a recombinant DNA that is part of a hybrid gene encoding additional polypeptide sequence. 30 The terms "isolated," "purified," or "biologically pure" refer to material that is free to varying degrees from components which normally accompany it as found in its native state. "Isolate" denotes a degree of separation from original source or surroundings. "Purify" denotes a degree of separation that is higher than isolation. A "purified" or "biologically 11 WO 2013/155056 PCT/US2013/035750 pure" protein is sufficiently free of other materials such that any impurities do not materially affect the biological properties of the protein or cause other adverse consequences. That is, a nucleic acid or peptide of this invention is purified if it is substantially free of cellular material, viral material, or culture medium when produced by recombinant DNA techniques, 5 or chemical precursors or other chemicals when chemically synthesized. Purity and homogeneity are typically determined using analytical chemistry techniques, for example, polyacrylamide gel electrophoresis or high performance liquid chromatography. The term "purified" can denote that a nucleic acid or protein gives rise to essentially one band in an electrophoretic gel. For a protein that can be subjected to modifications, for example, 10 phosphorylation or glycosylation, different modifications may give rise to different isolated proteins, which can be separately purified. As used herein, "obtaining" as in "obtaining an agent" includes synthesizing, purchasing, or otherwise acquiring the agent. By "reference" is meant a standard or control condition. As is apparent to one skilled 15 in the art, an appropriate reference is where an element is changed in order to determine the effect of the element. By "hybridize" is meant pair to form a double-stranded molecule between complementary polynucleotide sequences (e.g., a gene described herein), or portions thereof, under various conditions of stringency. (See, e.g., Wahl, G. M. and S. L. Berger (1987) 20 Methods Enzymol. 152:399; Kimmel, A. R. (1987) Methods Enzymol. 152:507). By "subject" is meant a mammal, including, but not limited to, a human or non-human mammal, such as a bovine, equine, canine, ovine, or feline. By "target nucleic acid molecule" is meant a polynucleotide to be analyzed. Such polynucleotide may be a sense or antisense strand of the target sequence. The term "target 25 nucleic acid molecule" also refers to amplicons of the original target sequence. Ranges provided herein are understood to be shorthand for all of the values within the range. For example, a range of 1 to 50 is understood to include any number, combination of numbers, or sub-range from the group consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40, 30 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. Unless specifically stated or obvious from context, as used herein, the term "or" is understood to be inclusive. Unless specifically stated or obvious from context, as used herein, the terms "a", "an", and "the" are understood to be singular or plural. 12 WO 2013/155056 PCT/US2013/035750 Unless specifically stated or obvious from context, as used herein, the term "about" is understood as within a range of normal tolerance in the art, for example within 2 standard deviations of the mean. About can be understood as within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05%, or 0.01% of the stated value. Unless otherwise clear from 5 context, all numerical values provided herein are modified by the term about. The recitation of a listing of chemical groups in any definition of a variable herein includes definitions of that variable as any single group or combination of listed groups. The recitation of an embodiment for a variable or aspect herein includes that embodiment as any single embodiment or in combination with any other embodiments or portions thereof. 10 Any compositions or methods provided herein can be combined with one or more of any of the other compositions and methods provided herein. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 depicts exemplary polymerase-arresting entity structures. Black = Stabilizer 15 Sequence, Blue = Nicking Enzyme Recognition Sequence, Green = Nicking Enzyme Spacer Sequence, Red = Target-Specific Recognition Sequence, A = Adenine, T = Thymine, G = Guanine, C = Cytosine, U = Uracil, mX = 2'-O-methyl RNA base. Underlined base(s) delineates the modified sequence segment. Figures 2A-2C depicts evaluation of dynamic range synthetic long-mer to Clavibacter 20 michiganensis sepidonicus (Cms) target DNA. Exemplary results from the titration of Cms synthetic "long-mer" target and detection via a fluorobeacon are shown. NEAR assay for Cms performed without input target nucleic acid is indicated as No Target Control (NTC). Figure 2A is a graph showing that the signal in the No Target Controls (NTC' s) was suppressed in the 2'-0-methyl modified primer/template-containing reactions. Figure 2B is a 25 graph showing that the Standard Curve displayed a wide dynamic range using the 2'-0 methyl template reactions. Figure 2C is a comparison of exemplary mass spectra data showing the elimination of non-specific amplification products in No Target Controls (NTC) of the Cms assay system using 2'-0-methyl modified primers/templates (right panel), as compared to unmodified primers/templates (left panel). To determine the effect of the 2'-0 30 methyl modified primers/templates on the generation of background products, samples (10 pl) of No Target Control reactions depicted in Figure 2A were analyzed via HPLC/Mass Spectrometry. Mass spectra data clearly demonstrate in the presence of 2'-0-methyl modified primers/templates the presence of only the expected molecular species was detected 13 WO 2013/155056 PCT/US2013/035750 and complex background products generated in the presence of unmodified primers/templates were eliminated. Figure 3 depicts 2'-O-methyl modification of templates/primers eliminated background signal in NEAR assay using SYBR Green detection. Exemplary amplification 5 data using 2'-O-methyl modified primers/templates and the elimination of non-specific amplification products are shown. Figure 3A is a graph showing that significant signal was observed in the No Target Controls (NTC's), indicating background product generation in the absence of target DNA. Figure 3B is a graph showing that in the 2'-0-methyl modified template-containing reactions signal in the No Target Controls (NTC's) was suppressed. 10 Figure 4 depicts 2'-O-methyl modification of templates/primers eliminated background signal in NEAR assay using Molecular Beacon detection. Exemplary amplification data using 2'-0-methyl modified primers/templates and the elimination of non specific amplification products are shown. Figure 4A is a graph showing that significant signal was observed in the No Target Controls (NTC's), indicating background product 15 generation in the absence of target DNA. Figure 4B is a graph showing that in the 2'-0 methyl modified template-containing reactions signal in the No Target Controls (NTC's) was suppressed. Figure 5 depicts exemplary polymerase arresting entities using 2'-O-methyl modified primers/templates or ratios of 2'-O-methyl modified primers/templates can be used to 20 manipulate both the time-to-detection and the efficiency of the reaction, thus 'tuning' the reactions. Schematic representations of exemplary 2'-0-methyl modified templates/primers for the tuning of a specific reaction are shown, including a primer/template having a block of five 2'-0-methyl nucleotides at the 3' end ("Terminal" template; left) and a primer/template having a block of five 2'-0-methyl nucleotides starting at the 3d nucleotide after the nick site 25 ("Nick +2" template"; right). Each tuning condition comprises specific ratios of forward and reverse templates with each set of templates having varying structures. Figure 6 depicts amplification plots demonstrating the utility of 2'-0-methyl modification of templates/primers for the 'tuning' of a specific reaction. Exemplary amplification data using 2'-0-methyl modified primers/templates are shown. All of the 30 reactions (in duplicate) contained 10,000 genome equivalents of Cms DNA. Each tuning condition represents specific ratios of forward and reverse templates with each set of templates having varying structures. The red circles demonstrate a shift in the time-to 14 WO 2013/155056 PCT/US2013/035750 detection for each tuning condition. Additionally, the log phase of each condition was contracted and the slope of the curve was shifted. Figures 7 depicts the design of two primer/template sets (TS3 & TS6) used in a NEAR assay to amplify a fragment of the corn ADHi gene. The target specific region in the 5 sequences of TS3 & TS6 primer/template sets are significantly longer (15 - 17 bases) than in primer/template sets of typical NEAR assays (9 to 12 bases) in the prior art. In the TS3 primer/template set the block of 5 consecutive 2'-O-methyl modified nucleotides adjacent to the 3'-terminus is preceded by an upstream region of 2'-0-methyl modified nucleotides alternating with unmodified nucleotides starting with a 2'-0-methyl modified nucleotide 5 or 10 4 nucleotides downstream from the nick site, respectively. In contrast to TS3, there are only five 2'-O-methyl modified nucleotides in each of the primers/templates of the TS6 set, which form a block of consecutive nucleotides adjacent to the unmodified 3'-terminal nucleotide. Figure 8 shows amplification plots of the ADHi assay using two sets of primers/templates (TS3 & TS6) recorded in the SYBRGreen dye detection channel. 15 Figure 9 shows the amplification plots of the same assay reactions recorded in the ROX channel. Figure 10 depicts the amplification plots of the NTC ADHi assay reactions recorded . Comparing the results shown in figure 8 and 9 it becomes evident that only the primer/template set TS3 produces the ADH 1-specific amplicon, while the signal generated by 20 set TS6 is mostly based on non-specific amplification of background products detected only by SYBRgreen. DETAILED DESCRIPTION OF THE INVENTION 25 The invention features compositions and methods that are useful for the quantification of a target nucleic acid molecule in an isothermal reaction. In particular embodiments, the invention provides compositions and methods for the quantification of a target nucleic acid molecule in a NEAR reaction (e.g., in real time). The invention is based, at least in part, on the surprising discovery that primer 30 template oligonucleotides comprising a 2' modified (e.g., 2'-0-methyl, 2'-Fluoro) nucleotide reduces or eliminates illegitimate amplification by 5'-3'exonuclease deficient derivatives of Bst DNA polymerase I. 15 WO 2013/155056 PCT/US2013/035750 NEAR Reaction. The NEAR reaction has been used as an endpoint reaction that provides for the non quantitative detection of target oligonucleotides. The conventional NEAR assay comprises 5 (1) a target nucleic acid molecule; (2) two oligonucleotide molecules that are analagous to the primer molecules of PCR; termed "template-primers" comprising some number of oligonucleotides that are complementary to the target nucleic acid molecule and a site that can be cleaved by a nicking enzyme; (3) dNTPs; (4) a strand displacing, 5'-3'-exonuclease deficient polymerase; and (5) a nicking enzyme. Current methods for quantifying the NEAR 10 reaction, particularly in real time, are inadequate due in part to the illegitimate amplification of non-target molecules present in a sample that can obscure detection of target sequences in a conventional NEAR reaction. For example, there is a consistent undesirable amplification in NEAR reactions that results in a detectable signal in the absence of a target molecule or with signals that do not accurately reflect the amount of target nucleic acid molecule present 15 in the reaction. Although this provides for detection of an endpoint product, it fails to provide for real time monitoring of the reaction. The present invention provides modified primer/template oligonucleotides that overcome the problem of accurately quantitating a target nucleic acid molecule in a NEAR reaction. It is particularly useful for quantitating a target nucleic acid molecule in a NEAR 20 reaction in real time. The invention is based, at least in part, on the discovery that primer template oligonucleotides comprising a 2' modified (e.g., 2'-O-methyl, 2'-Fluoro) reduces or eliminates illegitimate amplification without preventing the extension of those modified primer-templates in order to amplify the specific product. The primer/template oligonucleotides of the invention are useful in NEAR reactions comprising one or more of the 25 aforementioned NEAR components. In other embodiments, the invention provides for primer-template oligonucleotides comprising a 2' modified (e.g., 2'-O-methyl, 2'-Fluoro) that is positioned at or adjacent to the 3' terminus of the primer-template. Surprisingly, 2'-0-methyl nucleotides positioned in the 3'-terminal region of a primer-template not only do comprise effective priming substrates for 30 5'-3'-exonuclease deficient derivatives of Bst DNA polymerase I in isothermal DNA amplification reactions, but use of such modified primer-templates completely suppresses nonspecific primer-dimer amplification. This is particularly surprising because conventional thinking in the field of isothermal DNA amplification teaches that modified nucleotides (e.g., 16 WO 2013/155056 PCT/US2013/035750 2'-O-methyl ribonucleotides, unmodified ribonucleotides) could only be introduced at the 5' terminal region of the primer/template away the 3'-terminus, because placement of 2'-0 methoyl - as well as ribonucleotides within 6 nuleotides from the 3'-terminus of a primer had been demonstrated to inhibit primer extension by DNA polymerases(include as 5 references the paptent application from Amersham and the patent from Qiagen). 5'-3' exonuclease deficient derivatives of Bst DNA polymerase I used in NEAR and other isothermal amplification technologies (LAMP) belongs to polA-type bacterial DNA polymerases involved in low synthesis fidelity DNA repair processes. In contrast, high fidelity genome replication in bacteria is catalyzed by DNAE- & POLC type DNA 10 polymerase III holoenzymes, which utilize exclusively RNA primers to initiate DNA replication. In the published prior art the discrimination between RNA and DNA primers was thought to be one mechanism for preventing the interference of high error rate DNA polymerase I enzymes with high fidelity genome replication. In this context the surprising discovery that derivatives of Bst DNA polymerase I can efficiently utilize 2'-modified 15 ribonucleotides as primers for DNA synthesis is remarkable and counterintuitive. Primer-Template Design Exemplary polymerase-arresting entity structures from 5' to 3' comprise a stabilizer 20 sequence, nicking enzyme recognition sequence, nicking enzyme spacer sequence, and target specific recognition sequence, the target specific recognition sequence comprising one or more 2' modified nucleotides (e.g., 2'-O-methyl, 2'-methoxyethoxy, 2'-fluoro, 2'-allyl, 2'-0 [2-(methylamino)-2-oxoethyl], 2'-hydroxyl (RNA), 4'-thio, 4'-CH 2 -0-2'-bridge, 4'-(CH 2 ) 2-0 2-bridge, 2'-LNA, and 2'-O-(N-methylcarbamate)). Without being bound to theory, it is 25 hypothesized that incorporating one or more 2' modified nucleotides in the recognition regions renders those modified regions unsuitable to serve as template for polymerase extension in nonspecific intermolecular and/or intramolecular complexes formed by interactions of primers/templates (e.g., primer-dimer formation), and, thereby, reduces or eliminates the background signal in isothermal amplification. The 2' modified nucleotide 30 preferably has a base that base pairs with the target sequence. In particular embodiments, two or more 2' modified nucleotides (e.g., 2, 3, 4, 5 or more 2' modified nucleotides) in the target specific recognition region are contiguous (e.g., a block of modified nucleotides). In some embodiments, the block of 2' modified nucleotides is positioned at the 3' end of the 17 WO 2013/155056 PCT/US2013/035750 target specific recognition region. In other embodiments, the block of 2' modified nucleotides is positioned at the 5' end of the target specific recognition region. When the block of 2' modified nucleotides is positioned at the 5' end of the target specific recognition region, the 2' modified nucleotides may be separated from the nick site by one or more non 5 modified nucleotides (e.g., 2, 3, 4, 5 or more 2' unmodified nucleotides). Applicants have found that positioning of one or more 2' modified nucleotides or of a block of 2' modified nucleotides alters the kinetics of amplification. When the one or more 2' modified nucleotides or block of 2' modified nucleotides are positioned at or near the 5' end of the recognition region or proximal to the nick site, real-time amplification reactions showed 10 decreased time to detection. Additionally, the signal curve was contracted and the slope of the curve shifted. The applicants have alsofound that in recognition regions exceeding 12 nucleotides in length a single block of 5 consecutive 2'-modified nucleotide is not sufficient to suppress nonspecific amplification and therefore the entire recognition region up to 4 or 5 nucleotides downstream from the nick site must be substituted by 2'-modified nucleotides 15 alternating with unmodified nucleotides. In a related embodiment, ratios of a primer/template oligo having one or more 2' modified nucleotides can be used to alter the time-to-detection and/or the efficiency of the reaction for the 'tuning' of reactions, resulting in a predictable control over amplification kinetics. Increasing the ratio of primer/template oligo having one or more 2' modified 20 nucleotides at the 3' -end of the recognition sequence to primer/template oligo having one or more 2' modified nucleotides at the 5' end of the recognition sequence contracted the signal curve and shifted the slope of the curve. It is advantageous to be able to "tune" a reaction providing a means to manipulate both the time-to-detection as well as the efficiency of the reaction. Relative quantification using an internal control requires that two important 25 conditions be met. First, it is beneficial to be able to modify a reaction's time-to-detection creating a non-competitive reaction condition. Thus, by affecting the control reaction to be detectable at a later time-point (relative to the target of interest) the control reaction does not out-compete the specific target of interest even when the target of interest is in low initial abundance. Second, to ensure a true relative abundance calculation, it is required that the 30 control and specific target reactions have matched efficiencies. By controlling the efficiency of each reaction using a "tuning" condition enables reactions to be matched allowing for satisfactory relative quantification calculations. Tuning the reactions can be used to match efficiencies of target nucleic acid amplification and reference nucleic amplification (e.g., 18 WO 2013/155056 PCT/US2013/035750 internal standard) in quantitative PCR (qPCR). Additionally, amplification curves of the target nucleic acid and the internal standard may be altered so time of detection of their amplification products are separated, while providing the same efficiency for target nucleic acid amplification and internal standard amplification. Through the use of specific 5 combinations and ratios of oligonucleotide structures within a reaction it is possible to create conditions which enable tuned reaction performance. In various embodiments, primer/template pairs are constructed with a stem and loop configuration. The 5' end of the primer/template oligonucleotide comprises a self complementary region that forms at least part of the stem. In some embodiments of the 10 invention the stem further encompasses at least a portion or all of the nicking enzyme recognition sequence. In other various embodiments of the invention the nicking enzyme recognition sequence in the primers-templates is not part of the double stranded stem structure, but resides within the mostly single stranded loop. This nicking enzyme recognition site is linked at the 3' end to a secondary-structure-free site comprising a nicking site that is 15 linked at the 3' end to a sequence that is complementary to a target sequence. If desired, the sequence that is complementary to the target sequence may comprise a secondary structure or may be free of secondary structure. The presence of absence or secondary structure, which may comprise a self-complementary region, will be determined to optimize the particular NEAR assay. 20 In one embodiment, the methods of the invention provide a NEAR reaction that comprises the standard NEAR components, but also comprises an enzyme capable of nicking a RNA nucleotide when present in a heteroduplex with a complementary DNA strand. In one example, the cleaved RNA nucleotide will be present in a string of 4-15 non-cleavable RNA nucleotides (i.e. O-2-Me-RNAs) toward the 5' end of the target complementary region of the 25 PTO, and the 3' end of the template oligonucleotide will have a 3' terminal 'cap'. Only upon complete proper hybridization of the template oligonucleotide, with the heteroduplex cleaving molecule (i.e. RNase H) will be able to cleave the RNA base, creating a 3' end for the nick translation enzyme to extend from; and allowing the NEAR reaction to progress to completion. Aberrant template binding (primer dimers, partial non-target hybridization, etc) 30 will not lead to the RNA-DNA heteroduplex to form; and thus prevent the progression of the NEAR reaction. These templates will only be amplified after binding to a complementary nucleotide sequence through the removal of the 3' polymerase extension 'cap'. This will lead to an increased level of specificity and sensitivity of the NEAR reaction. 19 WO 2013/155056 PCT/US2013/035750 The template oligonucleotides of the invention are included in a NEAR reaction that comprises (1) a target nucleic acid molecule; (2) two template oligonucleotide molecules comprising some number of oligonucleotides that are complementary to the target nucleic acid molecule and a site that can be cleaved by a nicking enzyme and comprised of 4-15 5 RNA nucleotides, one of which is RNase liable; (3) dNTPs; (4) a strand displacing polymerase; (5) a nicking enzyme; and (6) a DNA-RNA heteroduplex RNA nicking enzyme and a 3' terminal polymerase extension cap. Accordingly, the invention provides a method of using these components to quantitate a target nucleic acid molecule. The method involves contacting a target nucleic acid molecule under substantially 10 isothermal conditions with a polymerase, two template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleotide molecule, a nicking enzyme, and a DNA-RNA heteroduplex nicking enzyme (e.g. RNase H) with a 3' terminal polymerase extension cap; generating a detectable amplicon that comprises at least a portion of a template oligonucleotide that binds a target sequence. 15 Target Nucleic Acid Molecules Methods and compositions of the invention are useful for the identification of a target nucleic acid molecule in a test sample. The target sequences is amplified from virtually any 20 samples that comprises a target nucleic acid molecule, including but not limited to samples comprising fungi, spores, viruses, or cells (e.g., prokaryotes, eukaryotes). In specific embodiments, compositions and methods of the invention detect Clavibacter michiganensis subsp. michiganensis, Clavibacter michiganensis subsp. sepedonicus, Pseudomonas syringae pv Tomato, Xanthomonas campestris pv Vesicatoria, Alternaria spp, Cladosporium spp, 25 Fusarium oxysporum, Verticilium dahlia, Pseudomonas currugata, Erwina carotovora, and Ralstonia solanacearum. Exemplary test samples include body fluids (e.g. blood, serum, plasma, amniotic fluid, sputum, urine, cerebrospinal fluid, lymph, tear fluid, feces, or gastric fluid), tissue extracts, culture media (e.g., a liquid in which a cell, such as a pathogen cell, has been grown), environmental samples, agricultural products or other foodstuffs, and their 30 extracts, DNA identification tags. If desired, the sample is purified prior to inclusion in a NEAR reaction using any standard method typically used for isolating a nucleic acid molecule from a biological sample. 20 WO 2013/155056 PCT/US2013/035750 In one embodiment, primer/template oligonucleotides amplify a target nucleic acid of a pathogen to detect the presence of a pathogen in a sample. Exemplary pathogens include fungi, bacteria, viruses and yeast. Such pathogens may be detected by identifying a nucleic acid molecule encoding a pathogen protein, such as a toxin, in a test sample. Exemplary 5 toxins include, but are not limited to aflatoxin, cholera toxin, diphtheria toxin, Salmonella toxin, Shiga toxin, Clostridium botulinum toxin, endotoxin, and mycotoxin. For environmental applications, test samples may include water, liquid extracts of air filters, soil samples, building materials (e.g., drywall, ceiling tiles, wall board, fabrics, wall paper, and floor coverings), environmental swabs, or any other sample. 10 In one embodiment disclosed herein, primer/template oligonucleotides amplify a target nucleic acid of plant used as an internal control in molecular breeding experiments geared towards improving, for example, the plant's resistance to drought, the plant's resistance to herbicides, to predation by harmful insects. One example of such an internal control target nucleic reduced to praxis herein is the ADHI gene (alcoholdehydrogenase 1) 15 from corn. Target nucleic acid molecules include double-stranded and single-stranded nucleic acid molecules (e.g., DNA, RNA, and other nucleobase polymers known in the art capable of hybridizing with a nucleic acid molecule described herein). RNA molecules suitable for detection with a detectable oligonucleotide probe or detectable primer/template 20 oligonucleotide of the invention include, but are not limited to, double-stranded and single stranded RNA molecules that comprise a target sequence (e.g., messenger RNA, viral RNA, ribosomal RNA, transfer RNA, microRNA and microRNA precursors, and siRNAs or other RNAs described herein or known in the art). DNA molecules suitable for detection with a detectable oligonucleotide probe or primer/template oligonucleotide of the invention include, 25 but are not limited to, double stranded DNA (e.g., genomic DNA, plasmid DNA, mitochondrial DNA, viral DNA, and synthetic double stranded DNA). Single-stranded DNA target nucleic acid molecules include, for example, viral DNA, cDNA, and synthetic single stranded DNA, or other types of DNA known in the art. In general, a target sequence for detection is between 10 and 100 nucleotides in length 30 (e.g., 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100 nucleotides. The GC content of the target nucleic acid molecule is selected to be less than about 45, 50, 55, or 60%. Desirably, the target sequence and nicking enzymes are selected such that the target sequence 21 WO 2013/155056 PCT/US2013/035750 does not contain nicking sites for any nicking enzymes that will be included in the reaction mix. Detectable Oligonucleotide Probes 5 The present invention provides for the quantitative detection of target nucleic acid molecules or amplicons thereof in a NEAR reaction using non-amplifiable detectable polynucleotide probescomprising at least one polymerase-arresting molecule (e.g., nucleotide modification or other moiety that renders the oligonucleotide capable of binding a target nucleic acid molecule, but incapable of supporting template extension utilizing the detectable 10 oligonucleotide probe as a target). Without wishing to be bound by theory, the presence of one or more moieties which does not allow polymerase progression likely causes polymerase arrest in non-nucleic acid backbone additions to the oligonucleotide or through stalling of a replicative polymerase (i.e. C3-spacer, damaged DNA bases, other spacer moiety, 0-2-Me bases). These constructs thus prevent or reduce illegitimate amplification of the probe during 15 the course of a NEAR reaction. This distinguishes them from conventional detection probes, which must be added at the end of the NEAR reaction to prevent their amplification. Conventional detection probes have proven impractical for quantitating a NEAR reaction in real time. If conventional detection probes are incorporated into the NEAR reaction, these conventional detection probes are amplified concurrently with the target. The 20 amplification of these detection molecules masks the detection of legitimate target amplicons due to the number of starting molecules of the detection detection probe at the start of the reaction. The invention provides non-amplifiable detectable polynucleotide probe that comprise least one polymerase-arresting molecule. A polymerase-arresting molecule of the invention 25 includes, but is not limited to, a nucleotide modification or other moiety that blocks primer template extension by replicative DNA polymerases, thereby preventing the amplification of detection molecules; but can allow proper hybridization or nucleotide spacing to the target molecule or amplified copies of the target molecule. In one embodiment, a detectable oligonucleotide probe of the invention comprises a 3 carbon spacer (C3-spacer) that prevents 30 or reduces the illegitimate amplification of a detection molecule. In one embodiment, the detectable oligonucleotide probe of the invention is a hair-pin shaped oligonucleotide comprising a detectable moiety. In another embodiment, the non amplifiable detectable polynucleotide probe is a hair-pin shaped oligonucleotide that 22 WO 2013/155056 PCT/US2013/035750 comprises a fluorophore on one end and a quenching dye on the opposite end. The loop of the hair-pin comprises a sequence that is complementary to and capable of hybridizing with a target sequence. The stem of the hair-pin is formed by annealing of complementary arm sequences located on either side of the loop. A fluorophore and a quenching molecule are 5 covalently linked at opposite ends of each arm. When the detectable oligonucleotide probe is in the hair pin configuration, the fluorescent and quenching molecules are proximal to one another, thereby leading to fluorescence resonance energy transfer (FRET) and quenching of the fluorescence of the fluorophore. When the detectable oligonucleotide probe encounters a target molecule, hybridization occurs; the loop structure is converted to a duplex 10 conformation with the target molecule, causing separation of the fluorophore and quencher molecules resulting in fluorescence (Tyagi et al. Nature Biotechnology 14: March 1996, 303 308). The detectable oligonucleotide probes are specific to the target sequence. In one embodiment, a detectable oligonucleotide probe comprises one or more modified nucleotide 15 bases having enhanced binding affinity to a complementary nucleotide. Examples of bases include, but are not limited to locked nucleic acids (LNA), 2' Fluoro amidites, and 2'OMe RNA amidites (also functioning as a polymerase arresting molecule). Detectable oligonucleotide probes of the invention can be synthesized with different colored fluorophores and may be designed to hybridize with virtually any target sequence. In view of 20 their remarkable specificity, a non-amplifiable detectable polynucleotide probe of the invention is used to detect a single target nucleic acid molecule in a sample, or is used in combination with detectable oligonucleotide probes each of which binds a different target nucleic acid molecule. Accordingly, the non-amplifiable detectable polynucleotide probes of the invention may be used to detect one or more target nucleic acid molecules in the same 25 reaction, allowing these targets to be quantitated simultaneously. The present invention encompasses the use of such fluorophores in conjunction with the detectable oligonucleotide probes described herein. Use of Non-Amplifiable Detectable Polynucleotide Probes 30 Non-amplifiable detectable polynucleotide probe are useful in methods for quantitating a target nucleic acid molecule in a nicking and extension amplification reaction (NEAR). The method involves contacting a target nucleic acid molecule under substantially isothermal conditions with a polymerase, two primer/template oligonucleotides, each of 23 WO 2013/155056 PCT/US2013/035750 which specifically binds to a complementary sequence on the target nucleotide molecule, a nicking enzyme, and the detectable oligonucleotide probe in the presence of a suitable buffer and dNTPs, generating amplicons comprising at least a portion of said target nucleic acid molecule; and determining the level of target nucleic acid molecule present in the reaction by 5 quantitating the oligonucleotide probe that hybridizes to the target nucleic acid molecule in real time during the reaction based on fluorescent intensity from the probe molecules in the reaction. Advantageously, such methods are useful for monitoring NEAR in real time. In general, non-amplifiable detectable polynucleotide probes of the invention are included in a NEAR reaction that comprises (1) a target nucleic acid molecule; (2) two 10 template oligonucleotide molecules comprising some number of oligonucleotides that are complementary to the target nucleic acid molecule and a site that can be cleaved by a nicking enzyme; (3) dNTPs; (4) a strand displacing polymerase; and (5) a nicking enzyme. Accordingly, the invention provides a method of using these components to quantitate a target nucleic acid molecule. 15 NEAR Assays The invention provides for the detection of target nucleic acid molecules amplified in a NEAR assay. Such assays are known in the art and described herein. See, for example, US Patent Application Publication 2009/0081670, PCT Application 2009/012246, and US Patent 20 Nos. 7,112,423 and 7,282,328, each of which is incorporated herein in its entirety. Polymerases useful in the methods described herein are capable of catalyzing the incorporation of nucleotides to extend a 3' hydroxyl terminus of an oligonucleotide (e.g., a primer/template oligonucleotide or other primer) bound to a target nucleic acid molecule. Such polymerases include those that are thermophilic and/or those capable of strand 25 displacement. Polymerases useful in methods described herein lack a 5'-3' exonuclease activity, which would otherwise degrade the displaced single stranded nucleic acid strand. olymerase also has reverse transcriptase activity (e.g., derivatives of Bst (large fragment) DNA polymerase, Therminator DNA polymerase, Therminator II DNA polymerase). Exemplary polymerases include, but are not limited to the Bst large fragments of Bst DNA 30 polymerase I, E. coli DNA polymerase I (Klenow fragment), Klenow fragment (3-5' exo-), T4 DNA polymerase, T7 DNA polymerase, Deep VentR. (exo-) DNA Polymerase, Deep VentR DNA Polymerase, , Therminator, Therminator II DNA Polymerase, AmpliTherm DNA Polymerase, SP6 DNA polymerase,. The following non-limiting examples of Reverse 24 WO 2013/155056 PCT/US2013/035750 Transcriptases (RT) can be used in the reactions of the present method to improve performance when detecting an RNA sequence: OmniScript (Qiagen), SensiScript (Qiagen), MonsterScript (Epicentre), Transcriptor (Roche), HIV RT (Ambion), SuperScript III (Invitrogen), ThermoScript (Invitrogen), Thermo-X (Invitrogen), ImProm II (Promega). 5 A nicking enzyme binds to a recognition sequence in double-stranded DNA and cleaves one strand of a double-stranded helix. Nicking enzymes may cleave either upstream or downstream of their recognition site or within the enzyme's recognition site. For methods disclosed herein, only nicking enzymes that cleave the top strand downstream of the recognition site can be used to launch repetitive cycles of substrate DNA nicking and nick 10 extension by the polymerase to drive exponential amplification of the target nucleic fragment between the primer-templates. Ideally, the nicking enzyme is functional under the same reaction conditions as the polymerase. In a preferred embodiment of the invention, the nicking enzyme is thermostable and active between 50'C and 60'C. Exemplary nicking enzymes useful for methods disclosed herein include, but are not limited to, Nt.BspQI(NEB), 15 Nt.BspD6I, Nt.BsmAI(NEB), , Nt.AlwI(NEB), Nt.BbvCI(NEB), N.Bst9I(Sibenzyme), and Nt.BstNBI(NEB),,. A NEAR reaction typically comprises nucleotides, such as, for example, dideoxyribonucleoside triphosphates (dNTPs). The reaction may also be carried out in the presence of dNTPs that comprise a detectable moiety including but not limited to a radiolabel 20 (e.g., 2p , 125, 3 S) an enzyme (e.g., alkaline phosphatase), a fluorescent label (e.g., fluorescein isothiocyanate (FITC)), biotin, avidin, digoxigenin, antigens, haptens, or fluorochromes. The NEAR reaction further comprises certain salts and buffers that provide for the activity of the nicking enzyme and polymerase. Advantageously, the NEAR reaction is carried out under substantially isothermal 25 conditions where the temperature of the reaction is more or less constant during the course of the amplification reaction. Because the temperature does not need to be cycled between an upper temperature and a lower temperature, the NEAR reaction can be carried out under conditions where it would be difficult to carry out conventional PCR. Typically, the reaction is carried out at about between 35 'C and 90 'C (e.g., 35, 37, 42, 60, 65, 70, 75, 80, or 85 C). 30 Advantageously, it is not essential that the temperature be maintained with a great degree of precision. Some variability in temperature is acceptable. Melt temperature (Tm) and reaction rate modifiers may also be used to lower the melting temperature of the oligonucleotides, such as (but not limited to) ethylene glycol and 25 WO 2013/155056 PCT/US2013/035750 glycerol. In addition, DNA polymerase reaction rate modifiers (such as dNTP and magnesium concentration) may be used to alter the reaction rate to lead to a greater quantification precision. This invention provides methods of monitoring a NEAR reaction in real time, 5 utilizing NEAR amplification strategy as described above and in patents US007112423B2 and US20090017452A1. In one embodiment, quantitative NEAR utilizes target nucleic acids amplification alongside a control amplification of known quantity. The amount of target nucleic acid can be calculated as an absolute quantification or a relative quantification (semi quantitative) based on the source of the control (exogenous or endogenous control). 10 Quantitation of the unknown nucleotide sequence can be achieved either through comparison of logarithmic threshold amplification of the unknown to a series of known target sequences in either a separate set of reactions or in the same reaction ; or as an internal endogenous or exogenous co-amplification product which produces a threshold value, indicative of either a positive result (if the unknown exceeds the threshold) or negative result 15 (if the unknown does not exceed the threshold). Applications The present invention provides for the real-time monitoring of the isothermal amplification NEAR reaction which can provide a quantitative measure of the amount of the 20 starting target nucleic acid. Compositions and methods of the invention are useful in human diagnostics, where a rapid quantitative answer is desired (e.g., detectable amplification in under 15, 10, 9, 8, 7, 6, 5 min. or less). In particular embodiments, the invention provides for the use of NEAR reaction assays in human diagnostics in clinical settings. In other embodiments, the invention provides for the use of NEAR reaction assays in diagnostic field 25 work, where access to thermocycling equipment is unavailable or would be prohibitively expensive. In still other embodiments, the invention provides for the use of NEAR reaction assays in an academic setting where rapid quantitative answers are desired. Kits 30 The invention also provides kits for the amplification of a target nucleic acid molecule. Such kits are useful for the detection or quantitation of a target nucleic acid in a biological sample obtained from a subject. Kits of the present invention may comprise, for example, one or more polymerases, forward and reverse primer-templates, and one or more 26 WO 2013/155056 PCT/US2013/035750 nicking enzymes, as described herein. Where one target is to be amplified, one or two nicking enzymes may be included in the kit. Where multiple target sequences are to be amplified, and the primer-templates designed for those target sequences comprise the nicking enzyme sites for the same nicking enzyme, then one or two nicking enzymes may be 5 included. Where the primer-templates are recognized by different nicking enzymes, more nicking enzymes may be included in the kit, such as, for example, 3 or more. In one aspect, the invention provides a kit for nucleic acid amplification comprising a DNA polymerase; a primary primer-template, a secondary primer-template, a nicking enzyme with specificity to a nicking enzyme recognition site within the primer-templates, and 10 deoxynucleotide triphosphates (dNTP' s) (e.g., in a buffered solution containing components sufficient for amplification). In various embodiments, the primary primer-templateand secondary primer-template, each have a 3'-end specific recognition region sequence complementary or substantially complementary to the target sequence, where the end specific recognition region comprises one or more 2' modified nucleotides; a 5'-end tail sequence 15 containing a nicking enzyme recognition site upstream of the 3'-end specific recognition region sequences; and a stabilizing sequence upstream (5') of the nicking enzyme binding site. In one aspect, the kits of the present invention comprise a homogenous mix of all NEAR reaction components, including, but not limited to, dNTP's, forward and reverse 20 primer-templates, nicking enzyme, polymerase, a detectable target specific polynucleotide probe, reaction buffer and stabilizers, except the target nucleic acid. The kits of the present invention may also comprise one or more of the components in any number of separate containers, packets, tubes (e.g., <0.2 ml, 0.2 ml, 0.6 ml, 1.5 ml, 5.0 ml, >5.0 ml), vials, microtiter plates (e.g., <96-well, 96-well, 384-well, 1536-well, >1536 25 well), ArrayTape, and the like, or the components may be combined in various combinations in such containers. In various embodiments, the kit further comprises a pair of primer template oligonucleotides capable of binding to and amplifying a reference sequence. In yet other embodiments, the kit comprises a sterile container which contains the primer-template oligonucleotides; such containers can be boxes, ampules, bottles, vials, tubes, bags, pouches, 30 blister-packs, or other suitable container form known in the art. Such containers can be made of plastic, glass, laminated paper, metal foil, or other materials suitable for holding nucleic acids. The components of the kit may, for example, be present in one or more containers, 27 WO 2013/155056 PCT/US2013/035750 for example, all of the components may be in one container, or, for example, the enzymes may be in a separate container from the templates. The components may, for example, be dried (e.g., dry residue), lyophilized (e.g., dry cake) or in a stable buffer (e.g., chemically stabilized, thermally stabilized). Dry components may, for example, be prepared by 5 lyophilization, vacuum and centrifugal assisted drying and/or ambient drying. In various embodiments, the polymerase and nicking enzymes are in lyophilized form in a single container, and the templates are either lyophilized, freeze dried, or in buffer, in a different container. In some embodiments, the polymerase, nicking enzymes, and the templates are, in lyophilized form, in a single container. In other embodiments, the polymerase and the 10 nicking enzyme may be separated into different containers. Kits may further comprise, for example, dNTPs used in the reaction, or modified nucleotides, cuvettes or other containers used for the reaction, or a vial of water or buffer for re-hydrating lyophilized components. The buffer used may, for example, be appropriate for both polymerase and nicking enzyme activity. 15 The kits of the present invention may also comprise instructions for performing one or more methods described herein and/or a description of one or more compositions or reagents described herein. Instructions and/or descriptions may be in printed form and may be included in a kit insert. A kit also may include a written description of an Internet location that provides such instructions or descriptions. 20 Kits may further comprise reagents used for detection methods (e.g., real-time or endpoint), such as, for example, hybridization probes or DNA binding dyes. Kits may further comprise reagents used for detection methods, such as, for example, reagents used for FRET, lateral flow devices, dipsticks, fluorescent dye, colloidal gold particles, latex particles, a molecular beacon, or polystyrene beads. Detection components may be incorporated into a 25 lateral flow device. The lateral flow device may be used at a point of care. The practice of the present invention employs, unless otherwise indicated, conventional techniques of molecular biology (including recombinant techniques), microbiology, cell biology, biochemistry and immunology, which are well within the purview 30 of the skilled artisan. Such techniques are explained fully in the literature, such as, "Molecular Cloning: A Laboratory Manual", second edition (Sambrook, 1989); "Oligonucleotide Synthesis" (Gait, 1984); "Animal Cell Culture" (Freshney, 1987); "Methods in Enzymology" "Handbook of Experimental Immunology" (Weir, 1996); "Gene 28 WO 2013/155056 PCT/US2013/035750 Transfer Vectors for Mammalian Cells" (Miller and Calos, 1987); "Current Protocols in Molecular Biology" (Ausubel, 1987); "PCR: The Polymerase Chain Reaction", (Mullis, 1994); "Current Protocols in Immunology" (Coligan, 1991). These techniques are applicable to the production of the polynucleotides and polypeptides of the invention, and, as such, may 5 be considered in making and practicing the invention. Particularly useful techniques for particular embodiments will be discussed in the sections that follow. The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the assay, screening, and therapeutic methods of the invention, and are not intended to limit the scope of what the 10 inventors regard as their invention. EXAMPLES Currently, the NEAR reaction is used to quickly and isothermally detect the presence or absence of a target oligonucleotide in a sample. Due to technical limitations, conventional 15 NEAR methods are unsuitable for quantifying target oligonucleotides in real time due, at least in part, to illegitimate amplification of non-target molecules in the sample, which obscures the detection and accurate quantification of target amplicons. The present invention provides compositions and methods that overcome these limitations by providing detectable primer/templates that are not susceptible to illegitimate amplification. In one embodiment, a 20 quantifiable NEAR assay employs a primer comprising one or more 2'-0-Me modifications that prevents or reduces the illegitimate amplification of non-target molecules during the NEAR reaction. Currently, the design of NEAR amplification assays is limited to very short regions within the target nucleic acid that have at least one naturally occurring nicking enzyme recognition site in close proximity. Strand displacement synthesis initiated from this 25 nick site provides single stranded target DNA molecules to which primer-templates with short target specific regions can bind and start the cycles of nicking/polymerase extension target amplification reactions. The present invention provides compositions and methods that overcome this limitation by utilizing primer-templates with longer target specific regions, which therefore are capable of strand invasion between 50'C to 60'C during the first phase of 30 the amplification reaction without the assistance of strand displacement synthesis. Longer target specific regions in primer-templates come with the disadvantage of providing more real estate to form nonspecific DNA hybrids with extendable 3'-ends that can launch synthesis of nonspecific amplification products. Compositions in the present invention mitigate that 29 WO 2013/155056 PCT/US2013/035750 disadvantage by extending the placement of 2'-modified nucleotides beyond a 3'-terminal block of five consecutive modified nucleotides to cover the entire target specific region utilizing an alternate sequence of 2'-modified and unmodified nucleotides. 5 Example 1: Primer-template oligonucleotides comprising 2'--O-methyl nucleotides reduce or eliminate background signal in NEAR amplification. When NEAR amplification is performed without input target nucleic acid (i.e., No Target Controls; NTC's) signal is generated despite the absence of template. Thus, generation of background signal has the potential to decrease the accuracy of target nucleic 10 acid quantitation using NEAR amplification. It was hypothesized that the background signal was generated, in part, by formation of primer-dimers by primer/template oligonucleotides. Without being bound to theory, polymerase arresting structures comprising 2' modified nucleotides could by used to reduce or eliminate intermolecular and/or intramolecular interactions of primers/templates (e.g., primer-dimer formation), and, thereby, reduce or 15 eliminate the background signal in NEAR assay. Exemplary polymerase-arresting entity structures from 5' to 3' comprise a stabilizer sequence, nicking enzyme recognition sequence, nicking enzyme spacer sequence, and target specific recognition sequence, the target specific recognition sequence comprising one or more 2' modified nucleotides (e.g., 2'-O-methyl ribonucleotides). Where two or more 2' 20 modified nucleotides are present in the target specific recognition sequence the 2' modified nucleotides may be contiguous (e.g., 2, 3, 4, 5 or more 2' modified nucleotides). Titration of Clavibacter michiganensis sepidonicus (Cms) synthetic double stranded target DNA molecule was evaluated using detection via a fluorobeacon. Target DNA was serially diluted from a stock solution of a synthesized 250 basepair DNA 'longmer' which was designed with 25 the target sequence and a single nick site. The signal in the No Target Controls (NTC's) was suppressed in the 2'-O-methyl modified template-containing reactions (Figure 2A). The Standard Curve displayed a wide dynamic range using the 2'-O-methyl template reactions (Figure 2B). Samples (10 pl) of the No Target Control reactions were analyzed via HPLC/Mass Spectrometry and confirmed 30 suppression of background amplification products (Figure 2C). The spectra derived from reactions using unmodified oligos showed a complex spectrum composed of multiple amplification products derived from non-specific background products along with unreacted templates (Figure 2C, left panel). The spectra derived from reactions using 2'-O-methyl 30 WO 2013/155056 PCT/US2013/035750 modified oligos showed a simple spectrum composed of unreacted templates without the presence of non-specific background products (Figure 2C, right panel). To study the effect of the 2'-0-methyl modified template-containing reactions on the amplification of a biological sample, genomic Clavibacter michiganensis sepidonicus (Cms) 5 was used as target DNA. Amplified products were detection by SYBR green, which detects double-stranded DNA (Figures 3A and 3B) or Molecular Beacons, which detected a specific product (Figures 4A and 4B). Standard reactions were carried out with DNA oligonucleotide templates (Figures 3A and 4A) and 2'-O-methyl modified template-containing reactions (DNAble) reactions were carried out with oligonucleotides containing a block of 5 10 contiguous 2'-O-methyl nucleotides at the 3'-end in the target specific recognition sequence (Figures 3B and 4B). The signal in the No Target Controls (NTC's) was suppressed in the 2'-O-methyl modified template-containing reactions (Figures 3B and 4B) whereas significant signal is observed in the No Target Controls (NTC's) (Figures 4A and 4B) indicating generation of background product in the absence of target DNA. 15 Thus, these results indicate that primers comprising 2'-0-methyl nucleotides reduce or eliminate background signal in NEAR amplification. Example 2: Positioning of 2'-O-methyl nucleotides in primer/template oligonucleotides altered time-to-detection and efficiency of NEAR reactions. 20 Exemplary polymerase arresting entities having 2'-O-methyl modified nucleotides at different positions within the specificity region were used in NEAR amplification reactions and their reaction kinetics studied. In particular, the primer/templates studied included a pair of oligonucleotides having a block of five 2'-O-methyl nucleotides placed at the 3' end of the specificity region or at the 5' end of the specificity region (2 nucleotides downstream of the 25 nick site) (Figure 5). Standard reactions were carried out in duplicate with a block of 2'-0 methyl nucleotides on the 3'-end or starting at the 3 d nucleotide after the nick site and continuing for 5 bases or a mixture of these two structures as indicated. Target DNA was genomic Clavibacter michiganensis sepidonicus (Cms). Detection was based on Molecular Beacon at a final concentration of 1OOnM. 30 Reaction rate modifying entities having 2'-0-methyl modified nucleotides at different positions within the specificity region of the primer/template oligonucleotide displayed different amplification kinetics (Figure 6). The reactions using primer/templates having a block of five 2'-0-methyl nucleotides at the 3' end showed decreased time to detection 31 WO 2013/155056 PCT/US2013/035750 ("Terminal" template; 170 sec) compared to primer/templates having a block of five 2'-0 methyl nucleotides starting at the 3d nucleotide after the nick site ("Nick +2" template"; 430 sec). Thus, it was hypothesized that ratios of the two primer/template oligos can be used to manipulate the time-to-detection and/or the efficiency of the reaction for the 'tuning' of 5 reactions. Reactions with varying ratios of "Terminal" template:"Nick +2" template showed intermediate time-to-detection between that of the two templates (Figure 6). Additionally, with increasing ratio of "Terminal" template:"Nick +2" template, the curve was contracted and the slope of the curve shifted. Thus, it was shown that positioning of 2' modified nucleotides in primer/template oligonucleotides and ratios of primer/template 10 oligonucleotides with differentially positioned 2' modified nucleotides altered time-to detection and efficiency of NEAR reactions. The invention is at least based in part on these discoveries. 15 Example 3: Complete suppression of nonspecific amplification in NEAR assays utilizing primer-templates with long target specific regions A NEAR assay for the quantification of the corn alcohol dehydrogenase 1 gene (ADHI) was designed utilizing two alternative sets of forward and reverse primer-templates (TS3 & TS3). No suitable nicking enzyme recognition site could be located within 500 20 nucleotides upstream or downstream from the target sequence region in corn gDNA. Both sets of primers-templates feature longer target complementary regions (16 and 19 nucleotides, respectively) capable of strand invasion mediated hybridization with the target DNA. In the first set (TS3) the target complementary regions of the forward and reverse primer-templates contain a block of 5 consecutive 2'-O-methyl modified ribonucleotides 25 immediately upstream from the 3'-terminal deoxynucleotide. The remainder of the target sequence complementary region comprises a sequence of alternating unmodified deoxynucleotides and 2'-0-methyl ribonucleotides starting five nucleotides (forward primer template) or four nucleotides (reverse primer-template) downstream from the nick site. The second set (TS6) of primer-templates features only a block of five 2'-0-methyl 30 ribonucleotides adjacent to the 3'-terminal unmodified deoxynucleotide, while the rest of the target complementary region comprises only unmodified dexynucleotides. Ten microliter NEAR reactions were set up in 50mM Tris pH 8.0, 15mM (NH4) 2

SO

4 , 15mM Na 2

SO

4 , and 15mM MgSO 4 using 3.84 U Warmstart 2.0 Bst DNA polymerase 1 32 WO 2013/155056 PCT/US2013/035750 (NEB), 10K copies of synthetic corn ADHI target DNA, 0.3 mM dNTP's, 3 U Nt.BstNBI nicking enzyme, 200 nM ROX/BHQ-labeled ADHI molecular beacon probe, 0.5X SYBRgreen dye (LifeTechnologies), 1000 nM TS3 or TS6 reverse primer -template and 100 nM TS3 or TS6 forward primer-template. A set of no target DNA control reactions (NTC) 5 were made up of the same components without the synthetic corn ADHI target DNA. All reactions were incubated at 56'C for 15 minutes and fluorescence signals recorded at 520 nm (SYBRgreen) and 610 nm (ROX). Comparing the amplification plots of the target DNA containing reactions in the SYBRgreen (Figure 8) and ROX (Figure 9) detection channels with amplification plots of the 10 NTC reactions in the SYBRgreen detection channel (Figure 10) Results reported herein were obtained using the following methods and materials unless indicated otherwise. 15 NEAR Amplification Reactions Reactions (50 pl) contained 15mM MgSO 4 , 0.3mM dNTPs, 19.2 units Bst Polymerase, 15 units n.BstNBI, 10OOnM template 1, and 200nM template 2. Target DNA was genomic Clavibacter michiganensis sepidonicus (Cms) or a "longmer" based on Cms 20 sequences. Templates and target were preincubated together at 56'C for 30 seconds in a total volume of 10 pl. Master mix of the remaining reaction components was preincubated at 56'C for 30 seconds in a total volume of 40 pl. Master mix was combined with the templates and target, and incubated at 56'C for 10 minutes with fluorescent detection (SYBR Green or Molecular Beacons) collected every 10 seconds during incubation. Reactions were 'heat 25 killed' with a 2 minute 95 C step followed by a return to room temperature. Cycle threshold (Ct) equivalents were determined for each reaction based on a curve fit formula in the Biorad IQ5 software and values were plotted on a graph using Microsoft Excel. A linear regression was carried out and a Correlation Coefficient (R 2) was determined. 30 Other Embodiments From the foregoing description, it will be apparent that variations and modifications may be made to the invention described herein to adopt it to various usages and conditions. Such embodiments are also within the scope of the following claims. 33 WO 2013/155056 PCT/US2013/035750 The recitation of a listing of elements in any definition of a variable herein includes definitions of that variable as any single element or combination (or subcombination) of listed elements. The recitation of an embodiment herein includes that embodiment as any single embodiment or in combination with any other embodiments or portions thereof. 5 This application may be related to International Patent Application No. PCT/US2011/047049, filed August 9, 2011, which claims the benefit of U.S. Provisional Application No.: 61/373,695, filed August 13, 2010, the entire contents of which are incorporated herein by reference. All patents and publications mentioned in this specification are herein incorporated by 10 reference to the same extent as if each independent patent and publication was specifically and individually indicated to be incorporated by reference. 34

Claims (49)

1. A method of quantifying a specific product in a nicking and extension amplification reaction, the method comprising: 5 (a) contacting a target nucleic acid molecule under substantially isothermal conditions with a polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, wherein each of the primer/template oligonucleotides comprises one or more 2' modified nucleotides in the sequence complementary to the target 10 nucleic acid molecule; (b) generating amplicons comprising at least a portion of said target nucleic acid molecule; and (c) detecting a signal specific for oligonucleotide probe hybridization to the target nucleic acid molecule or amplicon thereof, wherein the signal indicates the quantity of the 15 target nucleic acid molecule present in the sample or an amplicon thereof.

2. The method of claim 1, wherein the 2' modification is selected from the group consisting of 2'-0-methyl, 2'-methoxyethoxy, 2'-fluoro, 2'-hydroxyl, 2'-allyl, 2'-0-[2 (methylamino)-2-oxoethyl], 4'-thio, 4'-CH 2 -0-2'-bridge, 4'-(CH 2 ) 2 -0-2'-bridge, 2'-LNA, and 20 2'-0-(N-methylcarbamate) or those comprising base analogs.

3. The method of claim 1, wherein the one or more 2' modified nucleotides are positioned at the 3' end of the sequence complementary to the target nucleic acid molecule. 25

4. The method of claim 1, wherein the one or more 2' modified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule.

5. The method of claim 4, wherein the one or more 2' modified nucleotides positioned at the 5' terminus of the sequence complementary to the target nucleic acid molecule are 30 separated from the nick site by 1, 2, 3, 4, 5 or more unmodified nucleotides.

6. The method of any one of claims 1-5, wherein two or more 2' modified nucleotides are contiguous. 35 WO 2013/155056 PCT/US2013/035750

7. The method of claim 3, wherein 5 contiguous 2'-O-methyl modified nucleotides are positioned at the 3' end of the sequence complementary to the target nucleic acid molecule. 5

8. The method of claim 4, wherein 5 contiguous 2'-O-methyl modified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule.

9. The method of any one of claims 1-8, wherein the detecting step does not detect an amplicon of a non-target molecule. 10

10. The method of any one of claims 1-9, wherein the method is carried out in real time.

11. The method of any one of claims 1-10, wherein the method provides a semi quantitative and/or quantity threshold method of determining the amount of nucleic acid 15 molecule present in a biological sample prior to amplification.

12. The method of any one of claims 1-11, where positioning the one or more 2' modified nucleotides nearer the 5' end of the sequence complementary to the target nucleic acid molecule increases the detection time of amplification. 20

13. The method of any one of claims 1-12, further comprising the use of ratios of primer/template oligonucleotides to provide increased resolution of reaction products resulting from differing quantities of starting target material 25

14. The method of any one of claims 1-13, further comprising the use of an amplification rate modifier to provide increased resolution of reaction products resulting from differing quantities of starting target material.

15. The method of any one of claims 1-14, wherein the target nucleic acid molecule is a 30 DNA or RNA nucleic acid molecule.

16. The method of any one of claims 1-15, wherein the probe is SYBR green or a Molecular Beacon. 36 WO 2013/155056 PCT/US2013/035750

17. The method of any one of claims 1-15, wherein the probe is a non-amplifiable detectable polynucleotide probe comprising at least about 10 nucleotides that are complementary to a target sequence, a detectable moiety, and a polymerase-arresting 5 molecule, wherein the polymerase-arresting molecule prevents a polymerase from amplifying the probe under conditions that otherwise support polymerase activity.

18. A method for detecting a plurality of distinct reaction products produced in the course of a single reaction, the method comprising: 10 (a) contacting a target nucleic acid molecule under substantially isothermal conditions with a polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, wherein each of the primer/template oligonucleotides comprises one or more 2' modified nucleotides in the sequence complementary to the target 15 nucleic acid molecule; (b) generating amplicons comprising at least a portion of said target nucleic acid molecule; and (c) detecting a signal specific for oligonucleotide probe hybridization to the target nucleic acid molecule or amplicon thereof, wherein the signal indicates the quantity of the 20 target nucleic acid molecule present in the sample or an amplicon thereof.

19. A method of quantifying a specific product in a nicking and extension amplification reaction, the method comprising: (a) contacting a target nucleic acid molecule under substantially isothermal conditions 25 with a polymerase, two primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, wherein each of the primer/template oligonucleotides comprises 5 contiguous 2'-O-methyl modified nucleotides are positioned at the 3' end of the sequence complementary to the target nucleic acid molecule; 30 (b) generating amplicons comprising at least a portion of said target nucleic acid molecule; and 37 WO 2013/155056 PCT/US2013/035750 (c) detecting a signal specific for oligonucleotide probe hybridization to the target nucleic acid molecule or amplicon thereof, wherein the signal indicates the quantity of the target nucleic acid molecule present in the sample or an amplicon thereof. 5

20. The method of claim 18, wherein step (c) is carried out in real time to determine the quantity of target present in the reaction.

21. A method for monitoring in real time a nicking and extension amplification reaction, the method comprising: 10 (a) contacting a test sample with a polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, and a detectable polynucleotide probe, wherein each of the primer/template oligonucleotides comprises one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule under substantially 15 isothermal conditions; (b) generating amplicons comprising at least a portion of said target nucleic acid molecule; and (c) detecting a signal in real time, thereby quantitating of the target nucleic acid molecule(s). 20

22. The method of claim 21, wherein the test sample comprises a pathogen.

23. The method of claim 22, wherein the pathogen is a virus, bacteria, yeast or fungus. 25

24. The method of claim 21, wherein the test sample is a biological sample.

25. The method of claim 24, wherein the biological sample is a biological fluid, cell, or tissue sample. 30

26. The method of claim 25, wherein the biological fluid is urine, semen, vaginal secretion, or stool.

27. The method of claim 21, wherein the test sample is an environmental sample. 38 WO 2013/155056 PCT/US2013/035750

28. The method of claim 21, wherein step (c) is carried out in real time.

29. A method for monitoring in real time a target nucleic acid molecule in a NEAR 5 reaction, which comprises: (a) contacting a target nucleic acid molecule under substantially isothermal conditions with a polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, a heteroduplex specific nicking enzyme, and a detectable polynucleotide probe, wherein each 10 of the primer/template oligonucleotides comprises one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule; (b) generating amplicons comprising a target sequence that binds the detectable oligonucleotide probe; and (c) detecting a signal in real time, thereby quantitating the target nucleic acid 15 molecule.

30. A method for monitoring in real time a target nucleic acid molecule in a test sample, the method comprising: (a) contacting a target nucleic acid molecule under substantially isothermal conditions 20 with a polymerase, two or more primer/template oligonucleotides, each of which specifically binds to a complementary sequence on the target nucleic acid molecule, a nicking enzyme, a repair enzyme or proof reading enzyme, and a detectable polynucleotide probe, wherein each of the primer/template oligonucleotides comprises one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule; 25 (b) generating amplicons comprising a target sequence that binds the detectable oligonucleotide probe; and (c) detecting a signal in real time, thereby quantitating the target nucleic acid molecule. 30

31. The method of claim 30, wherein the test sample comprises a pathogen.

32. The method of claim 31, wherein the pathogen is a virus, bacteria, yeast or fungus. 39 WO 2013/155056 PCT/US2013/035750

33. The method of claim 30, wherein the test sample is a biological sample.

34. The method of claim 33, wherein the biological sample is a biological fluid, cell, or tissue sample. 5

35. The method of claim 34, wherein the biological fluid is urine, semen, vaginal secretion, or stool.

36. The method of claim 30, wherein the test sample is an environmental sample. 10

37. The method of claim 30, wherein step (c) is carried out in real time.

38. A kit for detecting a target sequence in a NEAR reaction, the kit comprising one or more primer/template oligonucleotides, which specifically binds to a complementary 15 sequence on the target nucleic acid molecule and comprises one or more 2' modified nucleotides in the sequence complementary to the target nucleic acid molecule, and directions for use of the primer/template oligonucleotide in methods of the invention.

39. An isolated oligonucleotide comprising from 5' to 3', 20 i) a first region, and ii) a second region, wherein the first region comprises a nicking enzyme recognition sequence; wherein the second region comprises at least 9 nucleotides that specifically bind a complementary sequence on a target nucleic acid molecule; and wherein the second region comprises one or 25 more 2' modified nucleotides.

40. The isolated oligonucleotide of claim 36, wherein the 2' modification is selected from the group consisting of 2'-O-methyl, 2'-methoxyethoxy, 2'-fluoro, 2'-hydroxyl, 2'-allyl, 2'-0 [2-(methylamino)-2-oxoethyl], 4'-thio, 4'-CH 2 -0-2'-bridge, 4'-(CH 2 ) 2 -0-2'-bridge, 2'-LNA, 30 and 2'-O-(N-methylcarbamate) or those comprising base analogs. 40 WO 2013/155056 PCT/US2013/035750

41. The isolated oligonucleotide of claim 39 or 40, wherein the one or more 2' modified nucleotides are positioned at the 3' terminus of the sequence complementary to the target nucleic acid molecule. 5

42. The isolated oligonucleotide of claim 39 or 40, wherein the one or more 2' modified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule.

43. The isolated oligonucleotide of claim 42, wherein the one or more 2' modified 10 nucleotides positioned at the 5' end of the sequence complementary to the target nucleic acid molecule are separated from the nick site by 1, 2, 3, 4, 5 or more unmodified nucleotides.

44. The isolated oligonucleotide of any one of claims 39-43, wherein two or more 2' modified nucleotides are contiguous. 15

45. The isolated oligonucleotide of claim 44, wherein the number of contiguous 2' modified nucleotides is 2, 3, 4, 5, or more.

46. The isolated oligonucleotide of any one of claims 39-45, wherein the nicking enzyme 20 recognition sequence is 5'-GAGT-3'.

47. The isolated oligonucleotide of claim 41, wherein 5 contiguous 2'-O-methyl modified nucleotides are positioned at the 3' end of the sequence complementary to the target nucleic acid molecule. 25

48. The isolated oligonucleotide of claim 42, wherein 5 contiguous 2'-0-methyl modified nucleotides are positioned at the 5' end of the sequence complementary to the target nucleic acid molecule. 30

49. An isolated oligonucleotide, wherein the oligonucleotide is one set forth in Figure 1. 41